Foundation Medicine Seeks "Go-To" Companion Diagnostic Status For Sequencing Test
This article was originally published in The Gray Sheet
Executive Summary
The firm is barely more than a year old, but Cambridge, Mass.-based Foundation Medicine has set its sights on offering a one-stop companion diagnostic for cancer treatments using next-generation genome sequencing.